2018, Number 1
<< Back Next >>
Vet Mex 2018; 5 (1)
Practical use of clinical cytology for the diagnosis of hepatic lipidosis in dairy cattle
Rodríguez FFL, Quiroz-Rocha G, Núñez OL, Aparicio CA, Salgado HEG
Language: English/Spanish
References: 36
Page: 1-14
PDF size: 802.93 Kb.
ABSTRACT
Hepatic lipidosis is a metabolic disorder that occurs frequently in dairy cattle. Its clinical evaluation on dairy farms is complex, as it is based on physical,
chemical and biological tests. The present study evaluates the practical use of hepatic cytology in dairy cattle and suggests that overall health and dairy production rates of animals are not compromised with this procedure.
Cell and blood samples were obtained from 25 randomly selected multiparous
Holstein dairy cows at three different times during the transition period
(at calving and at 10 and 21 days postpartum). The values of haematocrit, plasma protein, fibrinogen, and total and differential leucocyte counts were determined, together with total protein, albumin, glutamate dehydrogenase,
triacylglycerides, cholesterol and ß-hydroxybutyrate. Cytological results were classified by the detected degree of fatty infiltration, and haematological and metabolic results were compared between each sampled period. The health status and the daily milk production at each sampling stage were recorded.
Obtained results indicated that the animals did not show significant clinical
inflammation or a decrease in dairy production, which could be deemed
secondary to the cytological sampling. This technique is thus regarded as a feasible alternative for the diagnosis of hepatic lipidosis in dairy cattle.
REFERENCES
1.Stöber M. Enfermedades del hígado. In: Dirksen G, Gründer HD, Stöber R, ed-itors. Medicina interna y cirugía del bovino. 4th edition, vol. 1(1). Buenos Aires (AR): Inter-Médica, 2005; p. 589-605.
2.den Boer M, Voshol P, Kuipers F, et al. Hepatic Steatosis: A Mediator of the Met-abolic Syndrome. Lessons From Animal Models. Arterioscler Thromb Vasc Biol. 2004;24:644-9. doi: /10.1161/01.ATV.0000116217.57583.6e
3.Vernon RG. Lipid metabolism during lactation: A review of adipose tissue-liver interactions and the development of fatty liver. J Dairy Res, 2005;72:460-9. doi: 10.1017/S0022029905001299
4.Mulligan FJ, Doherty ML. Production diseases of the transition cows. Vet J, 2008;176:3-9. doi:10.1016/j.tvjl.2007.12.018
5.Bobe G, Young JW, Beitz DC. Invited review: Pathology, etiology, prevention and treatment of fatty liver in dairy cows. J Dairy Sci, 2004;87:3105-24. doi: 10.3168/jds.S0022-0302(04)73446-3
6.Quiroz-Rocha GF, Bouda J. Patología clínica de hígado. In: Nuñez Ochoa L, Bou-da J, editors. Patología clínica veterinaria. DF (MX): UNAM, 2007; p. 122-37.
7.Starke A, Haudum A, Weijers G, et al. Technical note: analysis of total lipids and triacylglicerol content in small liver biopsy samples in cattle. J Anim Sci, 2010;88:2741-50. doi: 10.2527/jas.2009-2599
8.Jorritsma R, Jorritsma H, Schukken YH, et al. Prevalence and indicators of post partum fatty infiltration of the liver in nine commercial herds in the Netherlands. Livest Prod Sci, 2001;68:53-60. doi: 10.1016/S0301-6226(00)00208-6
9.Reid IM. Incidence and severity of fatty liver in dairy cows. Vet Rec, 1980;107:281-4. doi: 10.1136/vr.107.12.281
10.Eddy RG. Metabolics disease. In: Andrews AH, Boyd H, Eddy RG, Blowey RW, editors. Bovine medicine disease and husbandry of cattle. Oxford (UK): Black-well Science, 2004;801-3.
11.Kalaitzakis E, Roubies N, Panousis N, Pourliotis K, Kaldrymidou E, Karatzias H. Clinicopathologic evaluation of hepatic lipidosis in periparturient dairy cattle. J Vet Intern Med, 2007;21:835-45. doi: 10.1111/j.1939-1676.2007.tb03029.x
12.Quiroz-Rocha GF, Leblanc S, Duffield T, et al. Evaluation of prepartum serum cholesterol and fatty acids concentrations as predictors of pospartum retention of the placenta in dairy cows. J Am Vet Med Assoc, 2009;234:790-793. doi: 10.2460/javma.234.6.790
13.LeBlanc S. Monitoring metabolic health of dairy cattle in the transition period. J Reprod Dev, 2010;56:S29-35.
14.Rosciani AS, Merlo WA, Insfrán RM, Ruíz Díaz Benitez, Locket M, Koscinkzu P. Caracterización citológica de hepatopatías en perros y gatos. Rev Vet, 2007;18:111-116.
15.Rosendo O, Mcdowell LR. Liver dry matter and liver lipids in periparturient dairy cows. Act Vet Brno, 2003;72:541-546.
16.Herdt TH, Goeders L, Emery RS, et al. Test for estimation of bovine hepatic lipid content. J Am Vet Med Assoc, 1983;182:953-955.
17.Bohn AA, Callan RJ. Cytology in food animal practice. Vet Clin N Am-Food A P, 2007;23:443-479. doi: 10.1016/j.cvfa.2007.07.007
18.Bauchart D. Lipid absorption and transport in ruminants. J Dairy Sci, 1993;76:3864-3881. doi: 10.3168/jds.S0022-0302(93)77728-0
19.Bauchart D, Gruffat D, Durand D. Lipid absorption and hepatic metabolism in ruminants. P Nutr Soc, 1996;55:39-47. doi: 10.1079/PNS19960010
20.Engelking LR. Lipid metabolism. In: Engelking LR, editor. Physiological chemistry: textbook of veterinary. Oxford (UK): Jackson, 2004:298-410.
21.Reid IM, Dew AM, Williams LA. Hematology of subclinical fatty liver in dairy cows. Res Vet Sci, 1984;37:63-65.
22.Zerbe H, Schneider N, Leibold W, Wensing T, Kruip TAM, Schuberth HJ. Altered funtional and immunophenotypical properties of neutrophilic granulocytes in postpartum cows associated with fatty liver. Theriogenology, 2000;54:771-786. doi: 10.1016/S0093-691X(00)00389-7 http://veterinariamexico.unam.mx14/14Clinical cytology of hepatic lipidosisDOI: http://dx.doi.org/10.21753/vmoa.5.1.386Vol. 5No. 1 January-March2018Short communication
23.Wood D and Quiroz-Rocha GF. Normal hematology of cattle. In: Weiss DJ and Wardrop J, editors. Schalm’s veterinary hematology. Iowa (US): Blackwell, 2000:829-834.
24.Weiss DJ and Perman V. Assessment of the hematopoietic system in ruminants. Vet Clin N Am Food A P, 1992;8:411-428. doi: 10.1016/S0749-0720(15)30732-5
25.West HJ. Effect on liver function of acetonaemia and the fat cow syndrome in cattle. Res Vet Sci, 1990;48:221-227.
26.Sevinc M, Basoglu A, Oztok I, Sandikci M, Birdane F. The clinical-chemical pa-rameters, serum lipoprotein and fatty infiltration of the liver in ketotic cows. Turk J Vet Anim Sci, 1998;22:443-447.
27.Reid IM, Roberts CJ. Subclinical fatty liver in dairy cows. Irish Vet J, 1983;37:104-110.
28.Rodríguez-Fierros FL. Uso y estandarización de la citología hepática como herra-mienta clínica para el diagnóstico de lipidosis hepática en vacas lecheras (Mas-ter thesis). DF (MX): UNAM, 2013.
Alonso-Castillo BA, Palucci-Marziele MH, Alonso-Castillo MM, Guzmán-Facundo FR, Gómez-Meza MV. 2008. Situaciones de la vida estresante, uso y abuso de alcohol y drogas en adultos mayores de Monterrey, México. Rev Latino-am Enfermagem, 16/especial.
Campo A, Díaz LA. 2007. Factores asociados con el consumo diario de cigarrillos en adultos entre 60 y 65 años: un estudio transversal. Colomb Med, 38 (4), 357-364.
Consejo Nacional de Población (CONAPO). Proyecciones de la población de México 2005-2050. México 2006. Consultado en octubre, 2012 http://www.conapo.gob.mx/es/CONAPO/Proyecciones_ de_la_poblacion_de_Mexico_2005-2050
Frank PI, Morris JA, Frank TL, Hazell ML, Hirsch S. Trends in smoking habits. 2004. A longitudinal population study. Fam Pract, 21: 33-38.
Guimaraes Borges GL, Mendoza Meléndez MA, López Brambila MA, García Pacheco JA, VelascoÁngeles LR, Beltrón Silva MA, Valdez Corchado PE, Medina-Mora ME, Rafael Camacho Solís R. 2014. Prevalencia y factores asociados al consumo de tabaco, alcohol y drogas en una muestra poblacional de adultos mayores del Distrito Federal. Salud Mental, 37, 15-25
Gutiérrez JP, Rivera Dommarco J, Shamah Levy T, Villalpando Hernández S, Franco A, Cuevas Nasu L, Romer Martínez M, Hernández Ávila M. 2012. Encuesta Nacional de Salud y Nutrición. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública. México.
O’Connell H, Chin A, Cunningham C, Lawlor B. 2003. Alcohol Use Disorders in Elderly Peopleredefining an age old problem in old age. BMJ, 327, 664-667.
Solís LR, Vélez A, Berumen D. 2000. Prevalencia del consumo de bebidas alcohólicas y problemas asociados en personas de la tercera edad que acuden a los servicios de atención primaria de la ciudad de México. Salud Mental V, 23 (3), 38-45.